Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 18 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nuvectis Pharma, Inc. | 1,793,068 | reported | 06 Jan 2026 | tx 23+616,399 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Jan 2026 | GRANT_AWARD | Nuvectis Pharma, Inc. | 150,000 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Nuvectis Pharma, Inc. | 150,000 | 0.00 USD | |
| 10 May 2024 | PURCHASE | Nuvectis Pharma, Inc. | 1,113 | 6.32 USD | first after silence |
| 03 Jan 2024 | GRANT_AWARD | Nuvectis Pharma, Inc. | 130,000 | 0.00 USD | |
| 21 Mar 2023 | PURCHASE | Nuvectis Pharma, Inc. | 420 | 11.99 USD | |
| 15 Mar 2023 | PURCHASE | Nuvectis Pharma, Inc. | 670 | 10.71 USD | |
| 12 Jan 2023 | GRANT_AWARD | Nuvectis Pharma, Inc. | 115,000 | 0.00 USD | |
| 21 Dec 2022 | PURCHASE | Nuvectis Pharma, Inc. | 500 | 7.65 USD | |
| 16 Nov 2022 | PURCHASE | Nuvectis Pharma, Inc. | 150 | 7.10 USD | |
| 17 Nov 2022 | PURCHASE | Nuvectis Pharma, Inc. | 150 | 7.20 USD | |
| 23 Sept 2022 | PURCHASE | Nuvectis Pharma, Inc. | 220 | 7.87 USD | |
| 02 Sept 2022 | PURCHASE | Nuvectis Pharma, Inc. | 404 | 8.31 USD | |
| 31 Aug 2022 | PURCHASE | Nuvectis Pharma, Inc. | 1,476 | 8.07 USD | |
| 01 Sept 2022 | PURCHASE | Nuvectis Pharma, Inc. | 1,530 | 8.07 USD | |
| 20 May 2022 | PURCHASE | Nuvectis Pharma, Inc. | 300 | 16.54 USD | |
| 17 May 2022 | PURCHASE | Nuvectis Pharma, Inc. | 142 | 19.55 USD | |
| 16 May 2022 | PURCHASE | Nuvectis Pharma, Inc. | 100 | 19.28 USD | |
| 12 May 2022 | PURCHASE | Nuvectis Pharma, Inc. | 58 | 16.61 USD | |
| 12 May 2022 | PURCHASE | Nuvectis Pharma, Inc. | 36 | 14.58 USD | |
| 12 May 2022 | PURCHASE | Nuvectis Pharma, Inc. | 1,184 | 15.85 USD | |
| 01 Apr 2022 | GRANT_AWARD | Nuvectis Pharma, Inc. | 60,000 | 0.00 USD | |
| 04 Feb 2022 | PURCHASE | Nuvectis Pharma, Inc. | 2,100 | 3.38 USD | |
| 07 Feb 2022 | PURCHASE | Nuvectis Pharma, Inc. | 846 | 3.47 USD |
1 purchase reported after at least 12 months of silence — most recent on 10 May 2024.